BioNTech SE (BNTX) Profit After Tax (2018 - 2025)
BioNTech SE (BNTX) posted Profit After Tax of -$355.0 million for Q4 2025, down 958.16% on a QoQ basis from -$33.6 million in Q3 2025, and down 228.03% year-over-year from $277.3 million in Q4 2024.
BioNTech SE (BNTX) has 8 years of Profit After Tax data on file, last reported at -$355.0 million in Q4 2025.
- In Q4 2025, Profit After Tax fell 228.03% year-over-year to -$355.0 million; the TTM figure through Dec 2025 stood at -$1.3 billion (down 76.14% YoY), while the FY2025 annual figure was -$1.3 billion, down 80.55% from the prior year.
- Profit After Tax eased to -$355.0 million in Q4 2025, from -$33.6 million in the prior quarter.
- Across five years, Profit After Tax topped out at $4.2 billion in Q1 2022 and bottomed at -$869.9 million in Q2 2024.
- A 5-year average of $1.1 billion and a median of $385.0 million in 2023 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2021 — Profit After Tax surged 827987404.69% — and 2024, when it slumped 319.57%.
- Year by year, Profit After Tax stood at $3.6 billion in 2021, then sank by 35.81% to $2.3 billion in 2022, then tumbled by 78.81% to $492.7 million in 2023, then plunged by 43.72% to $277.3 million in 2024, then tumbled by 228.03% to -$355.0 million in 2025.
- The last three Profit After Tax figures came in at -$355.0 million (Q4 2025), -$33.6 million (Q3 2025), and -$437.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.63 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | -355.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -355.03 Mn |
| Sep 30, 2025 | -33.55 Mn |
| Jun 30, 2025 | -437.62 Mn |
| Mar 31, 2025 | -437.37 Mn |
| Dec 31, 2024 | 277.30 Mn |
| Sep 30, 2024 | 217.56 Mn |
| Jun 30, 2024 | -869.91 Mn |
| Mar 31, 2024 | -342.31 Mn |
| Dec 31, 2023 | 492.67 Mn |
| Sep 30, 2023 | 174.83 Mn |
| Jun 30, 2023 | -207.33 Mn |
| Mar 31, 2023 | 539.03 Mn |
| Dec 31, 2022 | 2.32 Bn |
| Sep 30, 2022 | 1.80 Bn |
| Jun 30, 2022 | 1.78 Bn |
| Mar 31, 2022 | 4.15 Bn |
| Dec 31, 2021 | 3.62 Bn |
| Sep 30, 2021 | 3.79 Bn |
| Jun 30, 2021 | 3.36 Bn |
| Mar 31, 2021 | 1.36 Bn |
| Dec 31, 2020 | 437.45 |
| Sep 30, 2020 | 245.30 Mn |
| Jun 30, 2020 | 97.26 Mn |
| Mar 31, 2020 | 58.95 Mn |
| Dec 31, 2019 | -332.23 Mn |
| Sep 30, 2019 | 33.50 Mn |
| Jun 30, 2019 | 56.28 Mn |
| Mar 31, 2019 | 46.33 Mn |
| Dec 31, 2018 | -53.35 Mn |
| Sep 30, 2018 | 27.31 Mn |